Mapping placental signals: Potential to predict premature birth

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the mom’s blood that indicate labor and even early birth risks. This breakthrough could lead to simple tests predicting premature birth, making a big difference in maternal care. Read more about this under Article 1 below.

Article 1: Deciphering maternal-fetal cross-talk in the human placenta during parturition using single-cell RNA sequencing

During labor, scientists use single-cell RNA sequencing to explore communication between the mother and fetus in the human placenta. Analyzing a cell atlas, they find changes in transcriptomic activity in fetal stromal and maternal decidual cells during labor. The study identifies cell types and signaling pathways involved, suggesting placenta-derived single-cell signatures could be biomarkers for predicting preterm birth, even in early gestation. This approach offers insights into maternal-fetal interactions during parturition and may aid in noninvasive biomarker development. Read the full article here.

In summary: Potential preterm birth biomarkers through placental single-cell analysis

Article 2: Detection of chromosomal aneuploidy in ancient genomes

In ancient DNA, researchers used a new method to detect aneuploidies (unusual chromosomal counts) and distinguish them from contamination, even in low-coverage genomes (~0.0001-fold). Applied to British skeletal remains, it identified mosaic Turner syndrome, 47,XYY karyotype (Early Medieval), Klinefelter (47,XXY), and Down syndrome (trisomy 21). The approach, providing an accessible and automated framework, enhances understanding of ancient individuals, their biological traits, and historical perceptions of sex and diversity. Read the full article here.

In summary: Aneuploidies in ancient remains identified, revealing historical diversity

Article 3: Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

In non-small cell lung cancer (NSCLC), patients treated with PD-(L)1 blockade often develop acquired resistance, affecting > 60% of initial responders. The study identifies differential expression of inflammation and interferon (IFN) signaling in acquired resistance. Relapsed tumors exhibit distinct expression patterns of IFNγ response genes, associated with persistent IFN signaling, immune dysfunction, and mutations in antigen presentation genes. The findings suggest ongoing, altered IFN response in NSCLC resistance, providing insights for therapeutic strategies to reverse acquired resistance by reprogramming the persistently inflamed tumor microenvironment. Read the full article here.

In summary: Altered interferon response in NSCLC resistance, guiding therapeutic strategies

Article 4: Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

Alzheimer’s disease (AD) displays molecular diversity revealed through cerebrospinal fluid proteomics. Examining 1,058 proteins in AD patients (n = 419) versus controls (n = 187), five distinct AD subtypes emerge. Subtypes exhibit variations in neuronal hyperplasticity, innate immune activation, RNA dysregulation, choroid plexus dysfunction, and blood–brain barrier impairment. Each subtype aligns with specific AD genetic risk variants and demonstrates differences in clinical outcomes, survival times, and brain atrophy patterns. These findings emphasize AD’s molecular heterogeneity, emphasizing the importance of personalized medicine approaches in AD drug development. Read the full article here.

In summary: Five distinct Alzheimer’s disease subtypes identified that may guide treatment

References

[1] Garcia-Flores, V., Romero, R., Tarca, A. L., Peyvandipour, A., Xu, Y., Galaz, J., Miller, D., Chaiworapongsa, T., Chaemsaithong, P., Berry, S. M., Awonuga, A. O., Bryant, D. R., Pique-Regi, R., & Gomez-Lopez, N. (2024). Deciphering maternal-fetal cross-talk in the human placenta during parturition using single-cell RNA sequencing. Science translational medicine, 16(729), eadh8335. https://doi.org/10.1126/scitranslmed.adh8335  

[2] Anastasiadou, K., Silva, M., Booth, T., Speidel, L., Audsley, T., Barrington, C., Buckberry, J., Fernandes, D., Ford, B., Gibson, M., Gilardet, A., Glocke, I., Keefe, K., Kelly, M., Masters, M., McCabe, J., McIntyre, L., Ponce, P., Rowland, S., Ruiz Ventura, J., … Skoglund, P. (2024). Detection of chromosomal aneuploidy in ancient genomes. Communications biology, 7(1), 14. https://doi.org/10.1038/s42003-023-05642-z  

[3] Memon, D., Schoenfeld, A. J., Ye, D., Fromm, G., Rizvi, H., Zhang, X., Keddar, M. R., Mathew, D., Yoo, K. J., Qiu, J., Lihm, J., Miriyala, J., Sauter, J. L., Luo, J., Chow, A., Bhanot, U. K., McCarthy, C., Vanderbilt, C. M., Liu, C., Abu-Akeel, M., … Hellmann, M. D. (2024). Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer cell, S1535-6108(23)00441-5. Advance online publication. https://doi.org/10.1016/j.ccell.2023.12.013

[4] Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H., Reus, L. M., van der Lee, S., Wesenhagen, K. E. J., Lorenzini, L., Vermunt, L., Venkatraghavan, V., Tesi, N., Tomassen, J., den Braber, A., Goossens, J., Vanmechelen, E., Barkhof, F., Pijnenburg, Y. A. L., van der Flier, W. M., Teunissen, C. E., Berven, F. S., … Visser, P. J. (2024). Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles. Nature aging, 10.1038/s43587-023-00550-7. Advance online publication. https://doi.org/10.1038/s43587-023-00550-7